Search Within

Morana Vojnic

Formats
  1. Journal Article (11)
  2. Meeting Abstract (6)
Groups
  1. Department of Pathology and Laboratory Medicine (17)
  2. GSK Faculty (17)
  3. Human Oncology and Pathogenesis Program (17)
  4. Sloan Kettering Institute Postdocs (17)
  5. Tow Center for Developmental Oncology (TCDO) (17)
  6. Department of Medicine (12)

More Groups

People
  1. Marc Ladanyi (17)
  2. Romel Somwar (17)
  3. Elisa De Stanchina (13)
  4. Inna Khodos (12)
  5. Marissa Mattar (12)
  6. Alexander Drilon (9)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (4)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. Cancer Discovery (2)
  3. Cancer Research (2)
  4. Disease Models & Mechanisms (2)
  5. Journal of Thoracic Oncology (2)
  6. Communications Biology (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. Elsevier Inc. (3)
  3. American Society of Clinical Oncology (2)
  4. Company of Biologists (2)
  5. Nature Research (1)
  6. Oxford University Press (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Generation and characterization of patient-derived preclinical models from tumor cells isolated from cerebrospinal fluid
    Meeting Abstract

    Offin, M.; Vojnic, M.; Liu, Z.; Lui, A.; Siau, E.; Gladstone, E.; Mattar, M.; Khodos, I.; Drilon, A.; Boire, A.; more...
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy
    Meeting Abstract

    Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Activation of KRAS mediates resistance to targeted therapy in MET exon 14–mutant non–small cell lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Lu, D.; Kurzatkowski, C.; Vojnic, M.; Smith, R. S.; Sabari, J. K.; Tai, H.; Mattar, M.; Khodos, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Acquired BRAF fusions as a mechanism of resistance to EGFR therapy
    Meeting Abstract

    Vojnic, M.; Kurzatkowski, C.; Kubota, D.; Suzawa, K.; Liu, Z.; Mattar, M.; Khodos, I.; Poirier, J. T.; de Stanchina, E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Oncogenic KRAS mediates resistance to MET targeted therapy in non-small cell lung cancer (NSCLC) with MET mutations that induce exon14 skipping
    Meeting Abstract

    Suzawa, K.; Offin, M. D.; Kurzatkowski, C.; Liu, D.; Vojnic, M.; Smith, R. S.; Mattar, M.; Khodos, I.; de Stanchina, E.; Sabari, J. K.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save